Tyra Biosciences, Inc. · NASDAQ:TYRA

Farallon Capital Management, L.L.C.'s stake in Tyra Biosciences, Inc. fell below 5% (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Farallon Capital Management, L.L.C.'s stake in Tyra Biosciences, Inc. fell below 5%, 6,000 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
0%
Shares
6,000
Intent
Passive
What changed
Fell below 5%
Filed together
29 holders

The filing in full

HolderStakeShares
Farallon Capital Management, L.L.C.0%6,000
Farallon Capital Partners, L.P.0%0
Farallon Capital Institutional Partners, L.P.0%0
Farallon Capital Institutional Partners II, L.P.0%0
Farallon Capital Institutional Partners III, L.P.0%0
Four Crossings Institutional Partners V, L.P.0%0
Farallon Capital Offshore Investors II, L.P.0%0
Farallon Capital (AM) Investors, L.P.0%0
Farallon Capital F5 Master I, L.P.0%0
Farallon Healthcare Partners Master, L.P.0%0
Farallon Partners, L.L.C.0%0
Farallon Institutional (GP) V, L.L.C.0%0
Farallon F5 (GP), L.L.C.0%0
Farallon Healthcare Partners (GP), L.L.C.0%0
Dapice Joshua J.0%6,000
Dreyfuss, Philip D.0%6,000
Dunn Hannah E.0%6,000
Gehani, Varun N.0%6,000
Giauque, Nicolas0%6,000
Husen, Avner A.0%6,000
Kim, David T.0%6,000
Linn, Michael G.0%6,000
Luo Patrick (Cheng)0%6,000
Roberts, Jr., Thomas G.0%6,000
Saito Edric C.0%6,000
Short Daniel S.0%6,000
Spokes, Andrew J. M.0%6,000
Warren, John R.0%6,000
Wehrly, Mark C.0%6,000

Source

View original at SEC

Related